Personalised Prediction of Disease Course in Ulcerative Colitis Using Multimodal Machine Learning - Part of the Presager Project

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCopenhagen University Hospital, Hvidovre

About this trial

In patients achieving clinical remission following a flare, artificial intelligence can reliably predict a new flare within the next 12 months utilizing clinical and objective information at day 0 and week 8.

Secondary endpoints:

* An artificial intelligence model's precision in predicting a new flare within 2 and 3 years * An artificial intelligence model's precision to rule out patients who will not experience a new flare within 1, 2 and 3 year

Eligibility criteria

Qualifiers

Signed informed consent

Diagnosis of UC for at least 1 year

Relapse due to UC.

First endoscopic and histological evaluation of the flare

Disqualifiers

Well-founded doubt that the flare is due to other than the patients UC

Trial design

Treatments tested in this trial

  • Deep learning model

Treatment groups

No treatment groups listed